Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Conference/Events
Editas Medicine management to meet with Oppenheimer » 04:55
04/22/24
04/22
04:55
04/22/24
04:55
EDIT

Editas Medicine

$5.50 /

-0.065 (-1.17%)

Meeting to be held on…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Friday
Conference/Events
Editas Medicine management to meet with Oppenheimer » 16:36
04/19/24
04/19
16:36
04/19/24
16:36
EDIT

Editas Medicine

$5.50 /

-0.065 (-1.17%)

Meeting to be held on…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Thursday
Options
Crispr Therapeutics call volume above normal and directionally bullish » 14:06
04/18/24
04/18
14:06
04/18/24
14:06
CRSP

Crispr Therapeutics

$56.94 /

+1.38 (+2.48%)

Bullish option flow…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:18
04/18/24
04/18
11:18
04/18/24
11:18
ITCI

Intra-Cellular

$73.15 /

-3.52 (-4.59%)

, SNGX

Soligenix

/

+

, MRNS

Marinus Pharmaceuticals

$1.47 /

+0.03 (+2.08%)

, BHVN

Biohaven

$41.68 /

-2.37 (-5.38%)

, JAGX

Jaguar Health

/

+

, NCNA

NuCana

$4.05 /

-0.1 (-2.41%)

, CRBP

Corbus Pharmaceuticals

$37.26 /

-0.095 (-0.25%)

, NTLA

Intellia Therapeutics

$21.80 /

+0.29 (+1.35%)

These names in the…

Open Full Text

Recommendations
Crispr Therapeutics price target raised by $1 at Citi, here's why » 05:57
04/18/24
04/18
05:57
04/18/24
05:57
CRSP

Crispr Therapeutics

$55.56 /

-2.44 (-4.21%)

Citi raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Intellia Therapeutics announces first patient dosed in Phase 3 MAGNITUDE study » 07:38
03/18/24
03/18
07:38
03/18/24
07:38
NTLA

Intellia Therapeutics

$28.30 /

+0.8 (+2.91%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 12:50
03/14/24
03/14
12:50
03/14/24
12:50
AGIO

Agios Pharmaceuticals

$29.33 /

-0.69 (-2.30%)

, BLUE

Bluebird Bio

$1.35 /

-0.05 (-3.57%)

, CRSP

Crispr Therapeutics

$72.20 /

-2.61 (-3.49%)

, NVO

Novo Nordisk

$134.84 /

+1.36 (+1.02%)

, VRTX

Vertex Pharmaceuticals

$411.74 /

-1.45 (-0.35%)

Biotechnology Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 11:41
03/14/24
03/14
11:41
03/14/24
11:41
AGIO

Agios Pharmaceuticals

$29.52 /

-0.5 (-1.67%)

, BLUE

Bluebird Bio

$1.37 /

-0.035 (-2.50%)

, CRSP

Crispr Therapeutics

$72.88 /

-1.93 (-2.58%)

, NVO

Novo Nordisk

$134.03 /

+0.55 (+0.41%)

, VRTX

Vertex Pharmaceuticals

$411.00 /

-2.19 (-0.53%)

Biotechnology Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Crispr Therapeutics proposes to elect Christian Rommel to board of directors » 08:40
03/13/24
03/13
08:40
03/13/24
08:40
CRSP

Crispr Therapeutics

$75.31 /

-1.68 (-2.18%)

, BAYRY

Bayer

$7.24 /

-0.07 (-0.96%)

CRISPR Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised by $17 at Mizuho, here's why » 07:02
03/06/24
03/06
07:02
03/06/24
07:02
CRSP

Crispr Therapeutics

$80.97 /

-0.77 (-0.94%)

Mizuho raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Editas Medicine price target raised by $5 at Citi, here's why » 06:28
02/29/24
02/29
06:28
02/29/24
06:28
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

Citi raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Editas Medicine price target raised by $1 at Barclays, here's why » 05:45
02/29/24
02/29
05:45
02/29/24
05:45
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

Barclays analyst Gena…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Editas Medicine files automatic mixed securities shelf 17:28
02/28/24
02/28
17:28
02/28/24
17:28
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

 
Hot Stocks
Editas Medicine expects cash to fund operations into 2026 » 07:03
02/28/24
02/28
07:03
02/28/24
07:03
EDIT

Editas Medicine

$8.87 /

+0.8 (+9.92%)

Cash, cash equivalents,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Editas Medicine reports Q4 EPS (23c), consensus (54c) » 07:02
02/28/24
02/28
07:02
02/28/24
07:02
EDIT

Editas Medicine

$8.87 /

+0.8 (+9.92%)

Reports Q4 revenue $60M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Downgrade
Intellia Therapeutics just downgraded at Goldman Sachs, here's why » 09:18
02/23/24
02/23
09:18
02/23/24
09:18
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Goldman Sachs analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Guggenheim, here's why » 08:47
02/23/24
02/23
08:47
02/23/24
08:47
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Guggenheim analyst Debjit…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target raised by $1 at Canaccord, here's why » 07:22
02/23/24
02/23
07:22
02/23/24
07:22
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Canaccord raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Options
Crispr Therapeutics call volume above normal and directionally bullish » 10:25
02/22/24
02/22
10:25
02/22/24
10:25
CRSP

Crispr Therapeutics

$90.50 /

+8.31 (+10.11%)

Bullish option flow…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised by $9 at RBC Capital, here's why » 09:33
02/22/24
02/22
09:33
02/22/24
09:33
CRSP

Crispr Therapeutics

$82.19 /

+3.44 (+4.37%)

RBC Capital analyst Luca…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Intellia Therapeutics reports Q4 EPS ($1.46), consensus ($1.45) » 07:35
02/22/24
02/22
07:35
02/22/24
07:35
NTLA

Intellia Therapeutics

$26.84 /

-0.34 (-1.25%)

"We're off to a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised by $15 at Wells Fargo, here's why » 07:04
02/22/24
02/22
07:04
02/22/24
07:04
CRSP

Crispr Therapeutics

$82.19 /

+3.44 (+4.37%)

Wells Fargo raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised by $19 at Barclays, here's why » 05:31
02/22/24
02/22
05:31
02/22/24
05:31
CRSP

Crispr Therapeutics

$82.19 /

+3.44 (+4.37%)

Barclays analyst Gena…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised by $2 at Chardan, here's why » 18:26
02/21/24
02/21
18:26
02/21/24
18:26
CRSP

Crispr Therapeutics

$82.19 /

+3.44 (+4.37%)

, VRTX

Vertex Pharmaceuticals

$419.82 /

-0.85 (-0.20%)

Chardan raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Fly Intel: Pre-market Movers » 08:59
02/21/24
02/21
08:59
02/21/24
08:59
WIX

Wix.com

$125.13 /

-2.195 (-1.72%)

, ROCK

Gibraltar Industries

$85.08 /

-1.05 (-1.22%)

, CLH

Clean Harbors

$187.48 /

+1.235 (+0.66%)

, CRSP

Crispr Therapeutics

$78.75 /

-3.435 (-4.18%)

, BLCO

Bausch + Lomb

$14.59 /

+0.28 (+1.96%)

, NEO

NeoGenomics

$14.71 /

+0.36 (+2.51%)

, TOL

Toll Brothers

$103.58 /

+1.405 (+1.38%)

, ADI

Analog Devices

$189.43 /

+1.14 (+0.61%)

, VRSK

Verisk Analytics

$248.52 /

+3.88 (+1.59%)

, WING

Wingstop

$324.72 /

+5.46 (+1.71%)

, PANW

Palo Alto Networks

$366.17 /

-0.1 (-0.03%)

, TDOC

Teladoc

$20.50 /

-0.52 (-2.47%)

Check out this morning's…

Open Full Text

Earnings
Crispr Therapeutics reports Q4 EPS $1.10, consensus (7c) » 07:34
02/21/24
02/21
07:34
02/21/24
07:34
CRSP

Crispr Therapeutics

$78.75 /

-3.435 (-4.18%)

Reports Q4 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Options
Crispr Therapeutics options imply 7.2% move in share price post-earnings » 13:34
02/20/24
02/20
13:34
02/20/24
13:34
CRSP

Crispr Therapeutics

$78.47 /

-3.72 (-4.53%)

Pre-earnings options…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Baird, here's why » 07:14
02/16/24
02/16
07:14
02/16/24
07:14
NTLA

Intellia Therapeutics

$28.44 /

+0.16 (+0.57%)

, ALNY

Alnylam

$147.48 /

-16.66 (-10.15%)

Baird lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics to develop genomic medicines for CF » 07:43
02/15/24
02/15
07:43
02/15/24
07:43
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics announce collaboration » 07:36
02/15/24
02/15
07:36
02/15/24
07:36
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.